"Blemish Update 2026" is not a verified named event. The clearest documented U.S.
update is the FDA's May 22 switch of Differin Epiduo to nonprescription status for acne treatment in people 12 and older. In skincare, "blemishes" usually means acne. The 2026 evidence points to wider treatment access, continued limits on antibiotics, evolving isotretinoin safeguards, and substantial uncertainty around popular procedures and alternative remedies.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What changed for nonprescription acne treatment?
- Which treatments have the strongest support?
- Why antibiotic use needs limits
- When does isotretinoin enter the picture?
- What remains uncertain?
What changed for nonprescription acne treatment?
On May 22, 2026, the FDA switched Differin Epiduo—adapalene 0.1% combined with benzoyl peroxide 2.5%—from prescription to nonprescription use for people ages 12 and older. The change appears on the agency's Prescription to Nonprescription Switch List.
This is primarily an access change: eligible consumers no longer need a prescription for this specific acne treatment. It does not establish a universal regimen or extend the listed eligibility to children under 12. Before choosing the product, check three details:.
- The user is at least 12 years old.
- The active ingredients are adapalene 0.1% and benzoyl peroxide 2.5%.
- The decision concerns acne rather than another condition that merely resembles a blemish.
Which treatments have the strongest support?
Acne affects nearly 50 million Americans each year and about 85% of adolescents. It can also begin or persist in adulthood, particularly among women, according to the American Academy of Dermatology's acne guideline update. The AAD strongly recommends benzoyl peroxide, topical retinoids, topical and oral antibiotics, and combinations of these treatments.
The recommendations cover adults, adolescents, and children older than nine. "Strongly recommended" does not mean every option suits every case. It means these treatments have firmer evidence behind them than the procedures, supplements, and dietary approaches for which the guideline found insufficient evidence.
Why antibiotic use needs limits
Antibiotics remain evidence-supported acne treatments, but resistance makes their use a practical concern. The AAD advises limiting oral antibiotics and pairing topical or oral antibiotics with benzoyl peroxide to reduce that risk.
A treatment discussion involving antibiotics should therefore address: These constraints matter because antibiotic treatment is not simply a choice between convenience and strength. Its use can affect how well antibiotics continue to work against bacteria.
- Why an antibiotic is needed.
- Whether benzoyl peroxide is included.
- How oral antibiotic use will be limited.
- What happens if acne does not respond adequately.
When does isotretinoin enter the picture?
Isotretinoin remains an important option for severe acne, acne that threatens scarring, or cases that have not responded to standard treatment. Because the drug can cause embryo-fetal toxicity, the FDA uses the iPLEDGE risk-management program to prevent fetal exposure. The FDA delayed planned iPLEDGE modifications from August 8 to November 15, 2026, so the agency could test system changes and reduce the chance of interrupted access. Pretreatment pregnancy tests must still take place in a medical setting, according to the FDA's June 2026 iPLEDGE update.
Rules differ by country. UK regulators removed the second-prescriber sign-off for patients under 18 on January 22, 2026, while retaining other safeguards and requiring a patient information video before treatment, as detailed in the MHRA's isotretinoin guidance. That UK change does not alter U.S. iPLEDGE requirements.
What remains uncertain?
The AAD found insufficient evidence to recommend chemical peels, lasers or light devices, microneedling, dietary changes, vitamins, or plant-based alternatives for acne. "Insufficient evidence" does not prove that every such approach is ineffective; it means the available evidence did not support a guideline recommendation.
Before spending time or money on one of these options, ask what evidence supports it for acne, what outcome it is meant to improve, and how it compares with strongly recommended treatments. Do not assume that a popular procedure, supplement, or dietary strategy has evidence equivalent to benzoyl peroxide, topical retinoids, or recommended combination therapy.